STAGE IV RENAL CELL CANCER AJCC V8
Clinical trials for STAGE IV RENAL CELL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets rare cancers with no good options
Disease control Recruiting nowThis study is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can shrink rare cancers of the urinary and reproductive systems that have spread to other parts of the body. About 314 adults with these rare tumors will receive the drug combo. The…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 00:51 UTC
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors. The goal is to see if this combination is safe and helps the immune system attack cancer more effectively. …
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 00:50 UTC
-
Brain tumor radiation showdown: single dose vs. three doses
Symptom relief Recruiting nowThis study tests whether giving radiation in three smaller doses (fractionated SRS) works better than a single large dose (standard SRS) for people whose cancer has spread to the brain. About 269 adults with certain cancers (like lung, breast, or melanoma) will be randomly assign…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Apr 28, 2026 13:02 UTC